Premenstrual Disorders Tied to Earlier Natural Menopause
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Sept. 21, 2023 -- Premenstrual disorders (PMDs) are associated with a higher risk for early menopause, according to a study published online Sept. 19 in JAMA Network Open.
Yihui Yang, from the Karolinska Institutet in Stockholm, and colleagues examined whether women with PMDs have increased risks for early menopause and menopause-related vasomotor symptoms (VMS). The analysis included 3,635 participants in the Nurses’ Health Study II (June 1991 to June 2017).
The researchers found that early natural menopause (menopause at younger than 45 years) was reported by 17 women with PMDs (7.1 per 1,000 person-years) and 12 women without PMDs (2.7 per 1,000 person-years; adjusted hazard ratio, 2.67; 95 percent confidence interval, 1.27 to 5.59). Moderate or severe VMS was reported by 68.3 percent of women with PMDs and 55.3 percent of women without PMDs (adjusted odds ratio, 1.68; 95 percent confidence interval, 1.32 to 2.14). There was no association observed between PMDs and mild VMS (adjusted odds ratio, 0.99; 95 percent confidence interval, 0.76 to 1.28).
"PMDs may be indicative of underlying physiology linked to early menopause and VMS, suggesting a phenotype observable during the reproductive years that may allow clinicians to target women at risk of earlier menopause and subsequent health risks later in the life course," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
American Academy of Neurology, April 13-18
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians...
AAN: Half of Premenopausal Women Have Menstrual Migraines
FRIDAY, April 19, 2024 – More than half of premenopausal women report menstrual migraine (MM), according to a study presented at the annual meeting of the American Academy...
Menopausal Hormone Therapy Use Beyond 65 Years Beneficial
TUESDAY, April 16, 2024 -- Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.